|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/02 | |
| A61K 38/08 |
| (11) | Number of the document | 2793919 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12809126.1 |
| Date of filing the European patent application | 2012-12-21 | |
| (97) | Date of publication of the European application | 2014-10-29 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/005362 |
| Date | 2012-12-21 |
| (87) | Number | WO 2013/091896 |
| Date | 2013-06-27 |
| (30) | Number | Date | Country code |
| PCT/EP2011/0064 | 2011-12-21 | WO |
| (72) |
COMBETTE, Jean-Marc, FR
DELOCHE, Catherine, CH
|
| (73) |
Xigen Inflammation Ltd.,
Arch. Makariou III 195 Neocleous House, 3030 Limassol,
CY
|
| (54) | NOVEL JNK INHIBITOR MOLECULES FOR TREATMENT OF VARIOUS DISEASES |
| NOVEL JNK INHIBITOR MOLECULES FOR TREATMENT OF VARIOUS DISEASES |